These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 31367589)

  • 1. GNAQ and PMS1 Mutations Associated with Uveal Melanoma, Ocular Surface Melanosis, and Nevus of Ota.
    Toomey CB; Fraser K; Thorson JA; Goldbaum MH; Lin JH
    Ocul Oncol Pathol; 2019 Jun; 5(4):267-272. PubMed ID: 31367589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in GNA11 in uveal melanoma.
    Van Raamsdonk CD; Griewank KG; Crosby MB; Garrido MC; Vemula S; Wiesner T; Obenauf AC; Wackernagel W; Green G; Bouvier N; Sozen MM; Baimukanova G; Roy R; Heguy A; Dolgalev I; Khanin R; Busam K; Speicher MR; O'Brien J; Bastian BC
    N Engl J Med; 2010 Dec; 363(23):2191-9. PubMed ID: 21083380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fatal GNAQ-mutated CNS melanoma in an adolescent with nevus of Ota.
    Blundell AR; Moustafa D; Samore WR; Hawryluk EB
    Pediatr Dermatol; 2021 Mar; 38(2):497-499. PubMed ID: 33421174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation spectrum in
    Zhang ED; Zhang M; Li G; Zhang CL; Li Z; Zang G; Su Z; Zhang M; Xiang D; Zhao L; Zhu J
    Precis Clin Med; 2019 Dec; 2(4):213-220. PubMed ID: 35693877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Role of Mutation Rates of GNAQ or GNA11 in Cases of Uveal Melanoma in Japan.
    Ominato J; Fukuchi T; Sato A; Yamaguchi N; Kobayashi K; Cho H; Oyama T; Ajioka Y
    Appl Immunohistochem Mol Morphol; 2018 Oct; 26(9):658-663. PubMed ID: 28248732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent and Yet Unreported GNAQ and GNA11 Mutations are Found in Uveal Melanomas.
    Schneider B; Riedel K; Zhivov A; Huehns M; Zettl H; Guthoff RF; Jünemann A; Erbersdobler A; Zimpfer A
    Pathol Oncol Res; 2019 Oct; 25(4):1319-1325. PubMed ID: 29209985
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ultradeep sequencing detects GNAQ and GNA11 mutations in cell-free DNA from plasma of patients with uveal melanoma.
    Metz CH; Scheulen M; Bornfeld N; Lohmann D; Zeschnigk M
    Cancer Med; 2013 Apr; 2(2):208-15. PubMed ID: 23634288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uveal Melanoma:
    Psinakis F; Katseli A; Koutsandrea C; Frangia K; Florentin L; Apostolopoulou D; Dimakopoulou K; Papakonstantinou D; Georgopoulou E; Brouzas D
    Anticancer Res; 2017 Oct; 37(10):5719-5726. PubMed ID: 28982892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High throughput mass spectrometry-based mutation profiling of primary uveal melanoma.
    Daniels AB; Lee JE; MacConaill LE; Palescandolo E; Van Hummelen P; Adams SM; DeAngelis MM; Hahn WC; Gragoudas ES; Harbour JW; Garraway LA; Kim IK
    Invest Ophthalmol Vis Sci; 2012 Oct; 53(11):6991-6. PubMed ID: 22977135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeted next generation sequencing reveals unique mutation profile of primary melanocytic tumors of the central nervous system.
    van de Nes J; Gessi M; Sucker A; Möller I; Stiller M; Horn S; Scholz SL; Pischler C; Stadtler N; Schilling B; Zimmer L; Hillen U; Scolyer RA; Buckland ME; Lauriola L; Pietsch T; Waha A; Schadendorf D; Murali R; Griewank KG
    J Neurooncol; 2016 May; 127(3):435-44. PubMed ID: 26744134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GNAQ Q209R Mutations Are Highly Specific for Circumscribed Choroidal Hemangioma.
    Le Guin CHD; Metz KA; Kreis SH; Bechrakis NE; Bornfeld N; Zeschnigk M; Lohmann DR
    Cancers (Basel); 2019 Jul; 11(7):. PubMed ID: 31336681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Values of G-Protein Mutations in Metastatic Uveal Melanoma.
    Terai M; Shimada A; Chervoneva I; Hulse L; Danielson M; Swensen J; Orloff M; Wedegaertner PB; Benovic JL; Aplin AE; Sato T
    Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Frequent GNAQ, GNA11, and EIF1AX Mutations in Iris Melanoma.
    Scholz SL; Möller I; Reis H; Süßkind D; van de Nes JAP; Leonardelli S; Schilling B; Livingstone E; Schimming T; Paschen A; Sucker A; Murali R; Steuhl KP; Schadendorf D; Westekemper H; Griewank KG
    Invest Ophthalmol Vis Sci; 2017 Jul; 58(9):3464-3470. PubMed ID: 28700778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Uveal Melanomas in One Eye: A Choroidal Nevus Giving Rise to a Melanoma in an Eye with a Separate Large Choroidal Melanoma.
    Prager AJ; Habib LA; Busam KJ; Marr BP
    Ocul Oncol Pathol; 2018 Nov; 4(6):355-358. PubMed ID: 30574486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of oncogenic GNAQ mutations in melanocytic lesions of the conjunctiva as compared to uveal melanoma.
    Dratviman-Storobinsky O; Cohen Y; Frenkel S; Pe'er J; Goldenberg-Cohen N
    Invest Ophthalmol Vis Sci; 2010 Dec; 51(12):6180-2. PubMed ID: 20631239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Two discrete uveal melanomas in a child with ocular melanocytosis.
    Shields CL; Eagle RC; Ip MS; Marr BP; Shields JA
    Retina; 2006; 26(6):684-7. PubMed ID: 16829813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic impact of chromosomal aberrations and GNAQ, GNA11 and BAP1 mutations in uveal melanoma.
    Staby KM; Gravdal K; Mørk SJ; Heegaard S; Vintermyr OK; Krohn J
    Acta Ophthalmol; 2018 Feb; 96(1):31-38. PubMed ID: 28444874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncogenic G Protein GNAQ Induces Uveal Melanoma and Intravasation in Mice.
    Huang JL; Urtatiz O; Van Raamsdonk CD
    Cancer Res; 2015 Aug; 75(16):3384-97. PubMed ID: 26113083
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Involvement of mutant and wild-type CYSLTR2 in the development and progression of uveal nevi and melanoma.
    Nell RJ; Menger NV; Versluis M; Luyten GPM; Verdijk RM; Madigan MC; Jager MJ; van der Velden PA
    BMC Cancer; 2021 Feb; 21(1):164. PubMed ID: 33588787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Case Report:
    Prasuhn M; Freitag JC; Lüken S; Kakkassery V; Merz H; Caliebe A; Spielmann M; Ranjbar M; Rommel F
    Front Oncol; 2022; 12():873252. PubMed ID: 35692773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.